COVID Shots Should Target XBB Variants in 2023-24 Campaign

COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of the currently dominant XBB variants, say FDA staff reviewers.
Reuters Health Information

source https://www.medscape.com/viewarticle/993058?src=rss